The progression of Alzheimer’s disease was arrested in four patients who received an intravenous antibody treatment over three years, researchers reported at a conference in Vancouver, British Columbia.

Researchers noted that the results were inconclusive since they involved such a small group of patients. But with Alzheimer’s still mostly a mystery to medical science, any small step forward in treatment is good news.

— Posted by Alexander Reed Kelly

MedPage Today:

… The highlight finding, Relkin said, was that 3-year ADAS-Cog and CGIC scores in the four patients who received 0.4 g/kg every 2 weeks throughout the study were the same as at baseline.

Untreated Alzheimer’s disease patients in his clinic nearly always show measurable decline in 3 to 6 months, he said.

Read more

Your support matters…

Independent journalism is under threat and overshadowed by heavily funded mainstream media.

You can help level the playing field. Become a member.

Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.

Give today to support our courageous, independent journalists.